PTC-209 (hydrobromide)


CAS No. : 1217022-63-3

1217022-63-3
Price and Availability of CAS No. : 1217022-63-3
Size Price Stock
5mg $88 In-stock
10mg $154 In-stock
25mg $339 In-stock
50mg $594 In-stock
100mg $979 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-15888A
M.Wt: 576.10
Formula: C17H14Br3N5OS
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 1217022-63-3 :

PTC-209 hydrobromide is a specific BMI-1 inhibitor with an IC50 of 0.5 μM in HEK293T cell line. PTC-209 hydrobromide irreversibly impairs colorectal cancer-initiating cells (CICs). PTC-209 hydrobromide shows potent anti-myeloma activity and impairs the tumor microenvironment[1][2]. IC50 & Target: IC50: 0.5 μM (BMI-1, in HT1080 tumor cells)[1] In Vitro: PTC-209 (0.01-10 µM; 24-72 hours) induces a concentration- and time-dependent decrease in the cellular viability of all cell lines tested[2].
PTC-209 (1-2.5 μM) inhibits STAT3 phosphorylation in A549 lung cancer cells and MDA-MB-231 breast cancer cells[2]. In Vivo: PTC-209 (60 mg/kg body weight; subcutaneously; once a day for 11 days) significantly reduces tumor volume[2].

Your information is safe with us.